1. Home
  2. IMRX vs EVC Comparison

IMRX vs EVC Comparison

Compare IMRX & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • EVC
  • Stock Information
  • Founded
  • IMRX 2008
  • EVC 1996
  • Country
  • IMRX United States
  • EVC United States
  • Employees
  • IMRX N/A
  • EVC N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • EVC Broadcasting
  • Sector
  • IMRX Health Care
  • EVC Industrials
  • Exchange
  • IMRX Nasdaq
  • EVC Nasdaq
  • Market Cap
  • IMRX 232.9M
  • EVC 226.5M
  • IPO Year
  • IMRX 2021
  • EVC 2000
  • Fundamental
  • Price
  • IMRX $6.21
  • EVC $2.24
  • Analyst Decision
  • IMRX Strong Buy
  • EVC
  • Analyst Count
  • IMRX 4
  • EVC 0
  • Target Price
  • IMRX $17.75
  • EVC N/A
  • AVG Volume (30 Days)
  • IMRX 3.5M
  • EVC 190.0K
  • Earning Date
  • IMRX 11-12-2025
  • EVC 11-05-2025
  • Dividend Yield
  • IMRX N/A
  • EVC 8.93%
  • EPS Growth
  • IMRX N/A
  • EVC N/A
  • EPS
  • IMRX N/A
  • EVC N/A
  • Revenue
  • IMRX N/A
  • EVC $396,704,000.00
  • Revenue This Year
  • IMRX N/A
  • EVC $64.06
  • Revenue Next Year
  • IMRX N/A
  • EVC N/A
  • P/E Ratio
  • IMRX N/A
  • EVC N/A
  • Revenue Growth
  • IMRX N/A
  • EVC 25.34
  • 52 Week Low
  • IMRX $1.10
  • EVC $1.58
  • 52 Week High
  • IMRX $10.08
  • EVC $2.73
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 47.03
  • EVC 38.72
  • Support Level
  • IMRX $6.02
  • EVC $2.23
  • Resistance Level
  • IMRX $9.54
  • EVC $2.62
  • Average True Range (ATR)
  • IMRX 0.96
  • EVC 0.07
  • MACD
  • IMRX -0.36
  • EVC -0.02
  • Stochastic Oscillator
  • IMRX 4.68
  • EVC 11.28

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: